Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
11/2013
11/20/2013EP2190849B1 4-(9-(3,3-difluorocyclopentyl)-5,7,7-trimethyl-6-oxo-6,7,8,9-tetrahydro-5h-pyrimido[4,5-b[1,4]diazepin-2-ylamino)-3-methoxybenzamide derivatives as inhibitors of the human protein kinases plk1 to plk4 for the treatment of proliferative diseases
11/20/2013EP1781663B1 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament
11/20/2013CN103403010A Inhibitors of polo-like kinase
11/20/2013CN103403009A Macrocyclic inhibitors of flaviviridae viruses
11/20/2013CN103403008A Preparation method of intermediate of sitagliptin
11/20/2013CN103403007A 5,6-dihydro-imidazo[1,2-a]pyrazin-8-ylamine derivatives useful as inhibitors of beta-secretase (BACE)
11/20/2013CN103403006A 6-thio-substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
11/20/2013CN103403005A 5-([1,2,3]triazole-4-yl)-7h-pyrrolo[2,3-d]pyrimidine derivatives
11/20/2013CN103403001A Novel heterocyclic derivatives and their use in the treatment of neurological disorders
11/20/2013CN103402987A 6-amino-2-phenylamino-1H-benzimidazole-5-carboxamide- derivatives and their use as microsomal prostaglandin E2 synthase-1 inhibitors
11/20/2013CN103396419A Tumour photodynamic therapy medicine dihydroporphin e6-15-ethyl ester and preparation method thereof
11/20/2013CN103396418A Enzymatic preparation method of hemin by using dried yak blood as raw material
11/20/2013CN103396417A Novel hydroxamic acid derivative and medical application thereof
11/20/2013CN103396402A Substituted aminoindanes and analogs thereof, and pharmaceutical use thereof
11/20/2013CN103396398A Prokineticin 1 receptor antagonists
11/20/2013CN102643280B Folic-acid-modified phthalocyanino-silicon, and preparation method and application thereof
11/20/2013CN102056899B Polycyclic compound and organic electroluminescent device using the same
11/20/2013CN101983191B Oxim derivatives as hsp90 inhibitors
11/20/2013CN101952295B Pyrrolopyrazine kinase inhibitors
11/20/2013CN101870699B Benzenesulfonyl piperazine derivative and preparation method thereof
11/19/2013US8586783 4-biphenyl-substituted pyrazolidin-3,5-dione derivatives
11/19/2013US8586762 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same
11/19/2013US8586739 Heterocyclic compounds and their uses
11/19/2013US8586737 Process of a quaternary ammonium salt using phosphate
11/19/2013US8586609 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament
11/19/2013US8586597 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta
11/19/2013US8586596 Compounds as cannabinoid receptor ligands
11/19/2013US8586594 Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme
11/19/2013US8586584 Compounds for the treatment of hepatitis C
11/19/2013US8586581 Ethynyl compounds useful for treatment of CNS disorders
11/19/2013US8586577 Diazepane acetamide derivatives as selective 11B-HSD1 inhibitors
11/19/2013US8586576 Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
11/19/2013US8586505 4-(3-butynyl)aminopyrimidine derivatives as pest control agents for agricultural and horticultural use
11/19/2013CA2618340C Piperidine and piperazine derivatives as p2x3 antagonists
11/19/2013CA2591991C Triazolophthalazines
11/14/2013WO2013170243A1 Form 5 polymorph of 7-(tert-butyl-d9)-3-(2,5-difluorophenyl)-6((1-methyl-1h-1,2,4-triazol-5-yl)methoxy)-[1,2,4]triazolo[4,3-b]pyridazine
11/14/2013WO2013170242A1 Form 2 polymorph of 7-(tert-butyl-d9)-3-(2,5-difluorophenyl)-6-((1-methyl-1h-1,2,4-triazol-5-yl)methoxy)-[1,2,4]triazolo[4,3-b]pyridazine
11/14/2013WO2013170241A1 Polymorphs of 7-(tert-butyl-d9)-3-(2,5-difluorophenyl)-6-((1-methyl-1h-1,2,4-triazol-5-yl)methoxy)-[1,2,4]triazolol[4,3b]pyridazine
11/14/2013WO2013169546A1 Pyrazole compounds as sglt1 inhibitors
11/14/2013WO2013168807A1 Additive for graft cell suspension, and therapeutic composition
11/14/2013WO2013168709A1 Organic thin film solar cell, monomers and organic semiconductor material composition used in organic thin film solar cell
11/14/2013WO2013168001A1 Compositions and methods for the treatment of moderate to severe pain
11/14/2013WO2013167633A1 Acrylamide compounds for combating invertebrate pests
11/14/2013WO2013167177A1 Gpr17 receptor modulators.
11/14/2013US20130303760 New Process For The Preparation Of Nitroorotic Acid
11/14/2013US20130303570 Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
11/14/2013US20130303552 Novel inhibitors of secretion of hepatitis b virus antigens
11/14/2013US20130303551 Pyrimidinone derivatives as fatty acid synthase inhibitors
11/14/2013US20130303533 Azolopyridine and azolopyrimidine compounds and methods of use thereof
11/14/2013US20130303529 Fused heterocyclic derivatives and methods of use
11/14/2013US20130303520 NOVEL (HETEROCYCLE/TETRAHYDROPYRIDINE)-(PIPERAZINYL)-1-ALCANONE AND (HETEROCYCLE/DIHYDROPYRROLIDINE)-(PIPERAZINYL)-1-ALCANONE DERIVATIVES, AND USE THEREOF AS p75 INHIBITORS
11/14/2013US20130303511 Nampt inhibitors
11/14/2013US20130303507 Substituted hetero-biaryl compounds and their uses
11/14/2013US20130303505 Tgr5 agonists
11/14/2013US20130302416 Tricyclic derivatives, process for their preparation and their use as kinase inhibitors
11/14/2013US20130302357 Novel benzodiazepine derivatives
11/14/2013DE112012000807T5 Pyrrolo[2,1-c][1,4]naphthodiazepin-verknüpfte Piperazinverbindungen und Verfahren zu deren Herstellung Pyrrolo [2,1-c] [1,4] naphthodiazepine-linked piperazine compounds and process for their preparation
11/13/2013EP2662356A1 Condensed-cyclic compound and organic light emitting diode having organic layer including the same
11/13/2013EP2661438A2 New bicyclic compound for modulating g protein-coupled receptors
11/13/2013EP2661437A1 2,4-DIAMINO-6,7-DIHYDRO-5H-PYRROLO[2,3]PYRIMIDINE DERIVATIVES AS FAK/Pyk2 INHIBITORS
11/13/2013EP2661436A1 Novel sulfamide piperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof
11/13/2013EP2661268A2 Inhibitors of polo-like kinase
11/13/2013CN103391941A Imidazo[5,1-f][1,2,4]triazines for the treatment of neurological disorders
11/13/2013CN103391940A Substituted [(5h-pyrrolo[2,1-c] [1,4]benzodiazepin-11-yl)piperazin-1-yl]-2,2-dimethylpropanoic acid compounds as dual activity h1 inverse agonists/5-ht2a antagonists
11/13/2013CN103391939A Substituted purine and 7 - deazapurine compounds as modulators of epigenetic enzymes
11/13/2013CN103391924A Novel antiviral compounds
11/13/2013CN103387577A Asymmetric synthesis method of sitagliptin base
11/13/2013CN102105448B Phenoxypyridinylamide derivatives and use thereof in the treatment of PDE4 mediated disease states
11/13/2013CN102020646B Nicotinic acetylcholine receptorsub-type selective amides of diazabicycloalkanes
11/13/2013CN101965348B Process for preparing vardenafil and intermediates thereof
11/13/2013CN101671336B Aromatic heterocyclic pyridine derivatives and analogs and preparation method and application thereof
11/12/2013USRE44599 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
11/12/2013US8580959 Azolotriazinone melanin concentrating hormone receptor-1 antagonists
11/12/2013US8580833 Substituted imidazole derivatives and methods of use thereof
11/12/2013US8580803 Substituted pyrrolo-aminopyrimidine compounds
11/12/2013US8580802 Pyrrolo[2,3-D]pyrimidines as inhibitors of Janus kinases
11/12/2013US8580788 Opioid antagonists
11/12/2013US8580782 Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
11/12/2013US8580161 Fluidic devices comprising photocontrollable units
11/12/2013CA2651206C Bivalent smac mimetics and the uses thereof
11/12/2013CA2623334C High-purity texaphyrin metal complexes
11/07/2013WO2013166319A1 Macrocyclic and peptidomimetic compounds as broad-spectrum antivirals against 3c or 3c-like proteases of picornaviruses, caliciviruses and coronaviruses
11/07/2013WO2013166276A1 Triazolopyridazine compounds, use as inhibitors of the kinase lrrk2, and methods for preparation thereof
11/07/2013WO2013165189A1 Novel organic electroluminescence compounds and organic electroluminescence device containing the same
11/07/2013WO2013164790A1 L-malate salt of 2, 7 - diaza - spiro [4.5 ] dec- 7 - yle derivatives and crystalline forms thereof as ghrelin receptor agonists
11/07/2013WO2013164593A1 Pyrrolobenzodiazepines
11/07/2013WO2013164592A1 Pyrrolobenzodiazepines
11/07/2013WO2013164323A1 Pyrazole aminopyrimidine derivatives as lrrk2 modulators for use in the treatment of parkinson's disease
11/07/2013WO2013164061A1 Pyrrolotriazinone derivatives
11/07/2013WO2013163892A1 Novel triazolo pyrimidine compounds and a process of preparation thereof
11/07/2013US20130296565 L-malate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5h-pyrrolo[3,4-b]pyrazine
11/07/2013US20130296564 Synthesis of [2.2.2]-diazabicyclic ring systems
11/07/2013US20130296557 Diarylacetylene hydrazide containing tyrosine kinase inhibitors
11/07/2013US20130296554 C-17 bicyclic amines of triterpenoids with hiv maturation inhibitory activity
11/07/2013US20130296355 Glucagon receptor modulators
11/07/2013US20130296346 Diphenyl-amine derivatives: uses, process of synthesis and pharmaceutical compositions
11/07/2013US20130296343 Substituted imidazo- and triazolopyrimidines, imidazo- and pyrazolopyrazines and imidazotriazines
11/07/2013US20130296329 Quinoxaline compound
11/07/2013US20130296307 1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
11/07/2013US20130296305 Tricyclic pyrrolo derivatives, process for their preparation and their use as kinase inhibitors
1 ... 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 ... 573